Niccolo Gori - Publications

Corrigendum to "Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology" [Digestive and Liver Disease 58 (2026) 1051-1060].

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: August 30, 2026

Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real-World Study.

Journal: International journal of dermatology

Published: July 02, 2026

Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter Study.

Journal: Clinical and experimental dermatology

Published: April 12, 2026

Optimizing the use of novel systemic therapies in atopic dermatitis: an insight into therapeutic transitions.

Journal: Expert opinion on pharmacotherapy

Published: April 05, 2026

Tralokinumab for the treatment of moderate-severe atopic dermatitis in patients with a history of cancer.

Journal: Italian journal of dermatology and venereology

Published: March 27, 2026

Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

Journal: Dermatology and therapy

Published: March 11, 2026

Efficacy of abrocitinib in patients with atopic dermatitis resistant to Janus kinase inhibitors.

Journal: Skin health and disease

Published: February 18, 2026

IL-4/IL-13 targeted biologics in atopic dermatitis: is their use safe in oncologic patients?

Journal: Expert opinion on biological therapy

Published: February 05, 2026

Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: January 19, 2026

Beneficial effects of upadacitinib on a subgroup of patients with atopic dermatitis and hidradenitis suppurativa: a multicenter, real-world retrospective study.

Journal: Frontiers in immunology

Published: December 18, 2025

Head and neck atopic dermatitis: are Janus kinase inhibitors a game changer?

Journal: Expert opinion on pharmacotherapy

Published: December 14, 2025

Clinical Trial Eligibility in Atopic Dermatitis: Data from a Large Real-World International Cohort.

Journal: Dermatology and therapy

Published: November 14, 2025